S&P 500 Cons Disc Sector SPDR (XLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLY | NVO | JNJ | ||
| Company | S&P 500 Cons Disc Sector SPDR | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | ||
| Open | 224.55 | 110.22 | 151.29 | ||
| High | 226.37 | 110.52 | 151.56 | ||
| Low | 224.31 | 108.96 | 149.75 | ||
| Last | 226.15 | 108.97 | 150.47 | ||
| Change | +2.08 | -0.23 | -1.89 | ||
| % Change | +0.93% | -0.21% | -1.24% | ||
| Volume | 2,769,688 | 4,484,518 | 10,331,424 | ||
| 20-Day Average Volume | 3,140,800 | 5,895,425 | 8,142,305 | ||
| Previous Close | 224.07 | 109.20 | 152.36 | ||
| Industry | Finance - Investment Funds | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 217.84 | 105.81 | 154.34 | ||
| 20-Day Raw Stochastic | 98.93% | 83.33% | 6.49% | ||
| 20-Day Relative Strength | 71.50% | 46.99% | 34.96% | ||
| Weighted Alpha | +36.98 | -0.53 | -4.44 | ||
| Today's Opinion | 100% Buy | 88% Sell | 56% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.27% since 11/26/24 | +2.68% since 11/26/24 | -2.62% since 11/26/24 | ||
| Low | 219.51 on 11/27/24 | 104.96 on 11/27/24 | 149.75 on 12/04/24 | ||
| High | 226.37 on 12/04/24 | 110.88 on 12/03/24 | 156.63 on 11/27/24 | ||
| 1-Month | |||||
| %Chg | +13.42% since 11/04/24 | -0.68% since 11/04/24 | -4.91% since 11/04/24 | ||
| Low | 199.68 on 11/05/24 | 99.42 on 11/18/24 | 149.75 on 12/04/24 | ||
| High | 226.37 on 12/04/24 | 110.88 on 12/03/24 | 160.85 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | +22.22% since 09/04/24 | -19.00% since 09/04/24 | -10.09% since 09/04/24 | ||
| Low | 182.32 on 09/06/24 | 99.42 on 11/18/24 | 149.75 on 12/04/24 | ||
| High | 226.37 on 12/04/24 | 138.22 on 09/16/24 | 168.46 on 09/10/24 | ||
| 6-Month | |||||
| %Chg | +28.44% since 06/04/24 | -22.12% since 06/04/24 | +1.81% since 06/04/24 | ||
| Low | 166.48 on 08/05/24 | 99.42 on 11/18/24 | 143.88 on 06/13/24 | ||
| High | 226.37 on 12/04/24 | 148.15 on 06/25/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 23,644,397 | 490,038,528 | 366,825,440 | ||
| Shares Outstanding, K | 105,503 | 4,487,532 | 2,407,623 | ||
| Annual Sales | 0 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 0 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | N/A | 10,511,240,000 | 22,471,000,000 | ||
| Last Quarter Net Income | N/A | 4,024,170,000 | 2,694,000,000 | ||
| 60-Month Beta | 1.18 | 0.40 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.90 on 11/06/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | N/A | 11/06/24 | 01/28/25 | ||
| Most Recent Dividend | 0.405 on 09/23/24 | 0.362 on 08/16/24 | 1.240 on 11/26/24 | ||
| Next Ex-Dividends Date | 09/23/24 | 08/16/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 24.20 | 35.17 | 15.12 | ||